The Washington Research Foundation, a partner of the University of Washington Office of Technology Transfer has recently signed a licensing agreement with the French company, Cytheris S.A., for the interleukin-7 (IL-7) adjuvant technology. UW School of Pharmacy Professor Rodney JY Ho and Dr. Connie Faltynek described a novel and effective way to use Interleukin 7 to enhance humoral immunity or antibody response.  This technology is disclosed in the US Patent No. 5,714,141.

WRF: http://www.wrfseattle.org/
Cytheris: http://www.cytheris.com/history.html

Uploaded 11/07